Key advisors now set to back US listing for Astra
CAMBRIDGE: Leading shareholder advisory groups have backed plans by AstraZeneca, Britain’s most valuable public company,…
CAMBRIDGE: Leading shareholder advisory groups have backed plans by AstraZeneca, Britain’s most valuable public company,…